Serum butyraldehyde levels are associated with abdominal aortic calcification: a population-based study

Area of Science:

• Environmental health
• Cardiovascular research
• Metabolomics

Background:

• Abdominal aortic calcification (AAC) is a significant predictor of cardiovascular disease but lacks effective interventions.
• The role of aldehydes, both environmental and endogenous, in vascular calcification is not well understood.
• Investigating specific aldehydes may reveal novel insights into cardiovascular risk.

Purpose of the Study:

• To examine the association between serum aldehyde concentrations and AAC in a US adult population.
• To identify which specific aldehydes, if any, are linked to abdominal aortic calcification.
• To explore the potential of aldehydes in cardiovascular risk assessment and therapeutic development.

Main Methods:

• Utilized data from a nationally representative sample of US adults (NHANES 2013-2014).
• Measured abdominal aortic calcification (AAC) using dual-energy X-ray absorptiometry (DXA).
• Quantified six serum aldehydes using gas chromatography-mass spectrometry and analyzed associations with AAC using weighted logistic regression and quantile g-computation models.

Main Results:

• A significant inverse association was found between butyraldehyde concentration and AAC risk.
• Increased butyraldehyde levels were associated with a reduced risk of abdominal aortic calcification (AAC).
• Butyraldehyde showed the strongest inverse association with AAC among the aldehydes studied, particularly in individuals with klotho deficiency.

Conclusions:

• Butyraldehyde is inversely associated with abdominal aortic calcification (AAC), suggesting a potential protective role.
• Aldehyde-specific assessments may be necessary for comprehensive cardiovascular risk evaluation.
• Butyraldehyde presents a promising candidate for therapeutic strategies targeting vascular calcification in high-risk individuals.